Ovarian Cancer’s Hidden Threat? It’s in the Fluid, Not the TumorResearch reveals how ascites in ovarian cancer disrupts immunity, hindering tumor defense but offers potential treatment solutions.
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda RolloutMerck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
The Surprising Link Between Exercise and Cancer TreatmentA new study suggests that exercise can boost the effectiveness of cancer immunotherapy. The effects of exercise on cancer immunotherapy in patients with chronic lymphocytic leukemia were published in the journal Brain, Behavior, and Immunity. The research found that exercise can stimulate immune cells and enhance the body’s immunity, which is helpful for patients undergoing […]
Must-Reads
1
Coupang discloses 33m-user data breach to US regulators
LATEST
2
N. Korea's Kim pays respects to late father at family mausoleum on death anniversary
LATEST
3
Ex-vice land minister arrested over favoritism allegations related to presidential residence relocation
LATEST
4
Seoul stocks open higher amid mixed US job data
LATEST
5
US job growth snaps back; shutdown distorts unemployment rate
Ovarian Cancer’s Hidden Threat? It’s in the Fluid, Not the Tumor Research reveals how ascites in ovarian cancer disrupts immunity, hindering tumor defense but offers potential treatment solutions.
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout Merck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
The Surprising Link Between Exercise and Cancer Treatment A new study suggests that exercise can boost the effectiveness of cancer immunotherapy. The effects of exercise on cancer immunotherapy in patients with chronic lymphocytic leukemia were published in the journal Brain, Behavior, and Immunity. The research found that exercise can stimulate immune cells and enhance the body’s immunity, which is helpful for patients undergoing […]
Hot Topics